A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors
Clinical trial NCT06004245 · RECRUITING
Trial details
- NCT number
- NCT06004245
- Sponsor
- Vividion Therapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-01-25
- Primary completion
- 2027-05-31
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.